Mutational activation of FGFR3 is not involved in the development of prostate cancer.
Koufou S, Lunz JC, Borchardt A, Keck B, Kneitz B, Gaisa NT, Hafner C, Giedl C, Rau TT, Rogler A, Wieland WF, Hartmann A, Stoehr R.
Koufou S, et al. Among authors: lunz jc.
Pathobiology. 2010;77(5):249-52. doi: 10.1159/000317055. Epub 2010 Nov 29.
Pathobiology. 2010.
PMID: 21116115